Hertz Global Holdings, Inc. (HTZ) retreated with the stock falling -2.28% or $-0.53 to close at $22.76 on light trading volume of 2.75M compared its three months average trading volume of 3.92M. The Estero Florida 33928 based company operating under the Rental & Leasing Services industry has been trending down for the last 52 weeks, with the shares price now 0% down for the period and up by 5.57% so far this year. With price target of $30.86 and a 32.33% rebound from 52-week low, Hertz Global Holdings, Inc. has plenty of upside potential, making it a hold with a view buy.
Hertz Global Holdings, Inc., an airport general use car rental company, engages in the car rental business in North America, Europe, Latin America, Asia, Australia, Africa, the Middle East, and New Zealand. It operates the Hertz, Dollar, Thrifty, and Firefly car rental brands in approximately 9,980 corporate and licensee locations throughout approximately 150 countries. The company provides car rental for small and mid-sized businesses, meetings and conventions, associations/group programs, diversity programs, and government and military travelers. It offers airport general use car rental services serving approximately 1,635 airport locations in the U.S. and approximately 1,320 airport locations internationally. In addition, the company owns the vehicle leasing and fleet management business that operates the Hertz 24/7 hourly car rental business in international markets; and sells vehicles through its Rent2Buy program. Hertz Global Holdings, Inc. is based in Estero, Florida.
Allergan plc (AGN) had a light trading with around 2.72M shares changing hands compared to its three month average trading volume of 5.15M. The stock traded between $218.91 and $221.48 before closing at the price of $220.1 with 0.47% change on the day. The Dublin Dublin D17 E400 based company is currently trading 19.3% above its 52 week low of $184.5 and -28.09% below its 52 week high of $302.37. Both the RSI indicator and target price of and $261.58 respectively, lead us to believe that it could rise over the coming weeks.
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, womens health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, as well as dermatology and plastic surgery, and Alzheimers disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, it distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians offices. Allergan plc has a collaboration with T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Monsanto Company (MON) saw its value increase by 0.76% as the stock gained $0.82 to finish the day at a closing price of $108.95. The stock was higher in trading and has fluctuated between $83.73-$114.26 per share for the past year. The shares, which traded within a range of $107.4 to $109.05 during the day, are up by 5.95% in the past three months and up by 7.32% over the past six months. It is currently trading 3.95% above its 20 day moving average and 6.53% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $119.81 a share over the next twelve months. The current relative strength index (RSI) reading is 83.58.The technical indicator do not lead us to believe the stock will see more gains any time soon.
Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Channel, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands. It also develops biotechnology traits that assist farmers in controlling insects and weeds in corn, soybean, cotton, and canola crops under the SmartStax, YieldGard, YieldGard VT Triple, VT Triple PRO, and VT Double PRO brands; Intacta RR2 PRO brand; Bollgard and Bollgard II brands; Roundup Ready, Roundup Ready 2 Yield, and Genuity brands; and Roundup Ready 2 Xtend and Bollgard II XtendFlex brands. This segment also licenses a range of germplasm and trait technologies to large and small seed companies. The Agricultural Productivity segment manufactures and sells herbicides for agricultural, industrial, ornamental, turf, and residential lawn and garden applications for weed control, as well as for control of preemergent annual grass and small seeded broadleaf weeds in corn and other crops under the Roundup and Harness brands. The company markets its products through distributors, independent retailers and dealers, agricultural cooperatives, plant raisers, and agents, as well as directly to farmers. Monsanto Company has a collaborative agreement with Novozymes to discover, develop, and produce microbial solutions. The company was formerly known as Monsanto Ag Company and changed its name to Monsanto Company in March 2000. Monsanto Company was founded in 2000 and is headquartered in St. Louis, Missouri.